Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00041600 · ClinicalTrials.gov registry record
Human Epilepsy Genetics--Neuronal Migration Disorders Study
A clinical trial of Epilepsy and Cognition Disorder, sponsored by Harvard University Faculty of Medicine.
- Recruiting
- Registry status
- 3,500
- Enrollment target
- 1
- Study location
NCT00041600: Recruiting study of Epilepsy and Cognition Disorder, sponsored by Harvard University Faculty of Medicine.
NCT00041600 is a study of Epilepsy and Cognition Disorder that is actively recruiting participants, run by Harvard University Faculty of Medicine. The registered enrollment target is 3,500 participants, above the 931-participant average among 160 other Epilepsy trials with a reported enrollment target (276% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00041600, a study of Epilepsy and Cognition Disorder, is actively recruiting participants, sponsored by Harvard University Faculty of Medicine.
- RECRUITING
- Registry status
- 3,500 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify genes responsible for epilepsy, brain malformations and disorders of human cognition.
Primary Outcome
Genetic variants associated with disorder of brain development
Conditions Studied
Study Locations (1)
Massachusetts
- Boston Children's Hospital, Walsh Laboratory - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,500 participants |
| Start Date | 1996-04 |
| Est. Completion | 2030-06 |
What NCT00041600 shows while recruiting
NCT00041600 is an observational study that tracks outcomes without assigning an intervention. Its 3,500 participants enrollment target places it among the larger protocols in the corpus, above the 931-participant average among 160 other Epilepsy trials with a reported enrollment target (276% higher).
The record links to 4 conditions, with Epilepsy appearing as the primary indexed condition, and to 0 interventions.
NCT00041600 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00041600 about?
NCT00041600 is a clinical study titled "Human Epilepsy Genetics--Neuronal Migration Disorders Study". The purpose of this study is to identify genes responsible for epilepsy, brain malformations and disorders of human cognition.
What is the current status of trial NCT00041600?
This trial is currently recruiting. The enrollment target is 3,500 participants. The study started on 1996-04. Estimated completion is 2030-06.
What conditions does trial NCT00041600 study?
This clinical trial studies the following conditions: Epilepsy, Cognition Disorder, Brain Malformation, Neuronal Migration Disorder.
Who is sponsoring clinical trial NCT00041600?
This trial is sponsored by Harvard University Faculty of Medicine, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00041600 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00041600's enrollment target sits among peer trials
3,500 5th of 160 higher than 156 of 160 other Epilepsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
RECRUITING
-
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
RECRUITING
-
SeizEAR Safety Study
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Tumor Related Epilepsy
RECRUITING
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260559 · 3,500 participants
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
- NCT01612949 · 3,500 participants
Facial Analysis to Classify Difficult Intubation
- NCT02398786 · 3,500 participants
Myotonic Dystrophy Family Registry
- NCT03486873 · 3,500 participants · Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia